Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis

Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis

Kristian Thorlund,1 Eric Druyts,2 J Antonio Avi&ntilde;a-Zubieta,3,4 Edward J Mills1,21Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; 2Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada; 3Department of Medicine, U...

Full description

Bibliographic Details
Main Authors:	Thorlund K, Druyts E, Avi&ntilde;a-Zubieta JA, Mills EJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-12-01
Series:	Biologics: Targets & Therapy
Online Access:	http://www.dovepress.com/anti-tumor-necrosis-factor-tnf-drugs-for-the-treatment-of-psoriatic-ar-a11662

Similar Items

Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection
by: Druyts E, et al.
Published: (2013-06-01)

Boceprevir and telaprevir for the treatment of chronic hepatitis C genotype 1 infection: an indirect comparison meta-analysis
by: Cooper CL, et al.
Published: (2012-03-01)

Tumor necrosis factor (TNF)-α gene +489 polymorphisms: association with psoriatic arthritis
by: G. Murdaca, et al.
Published: (2013-01-01)

Drug resistance in anti-TNF therapy of psoriatic arthritis
by: Dominika Ligia Wcisło-Dziadecka, et al.
Published: (2018-11-01)

SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin
by: Thorlund K, et al.
Published: (2014-01-01)

Incorporating alternative design clinical trials in network meta-analyses
by: Thorlund K, et al.
Published: (2014-12-01)

Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
by: Vladimir Vasilyevich Badokin, et al.
Published: (2010-12-01)

Tumor necrosis factor-? inhibitors in therapy for psoriatic arthritis
by: Vladimir Vasilyevich Badokin, et al.
Published: (2010-12-01)

Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis
by: C. Salvarani, et al.
Published: (2004-09-01)

Nailfold Videocapillaroscopy in Patients with Rheumatoid Arthritis and Psoriatic Arthropathy on ANTI-TNF-ALPHA Therapy
by: Daniela Anghel, et al.
Published: (2023-06-01)

Regulatory T cells enhance Th17 migration in psoriatic arthritis which is reversed by anti-TNF
by: Dao X. Nguyen, et al.
Published: (2021-09-01)

Severe glandular tularemia in a patient treated with anti-tumour necrosis factor for psoriatic arthritis
by: Ruxandra Calin, et al.
Published: (2017-07-01)

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection
by: El Khoury AC, et al.
Published: (2012-11-01)

Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
by: Melissa A Michelon, et al.
Published: (2010-05-01)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
by: Fabrizio Cantini, et al.
Published: (2017-01-01)

THE EFFECT OF AN ANTI-TUMOR NECROSIS FACTOR-? AGENT ON DISEASE ACTIVITY,BLOOD RHEOLOGICAL PROPERTIES, AND THE ARTERIAL WALL IN PSORIATIC ARTHRITIS
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2010-06-01)

Pesquisa de autoanticorpos em pacientes com artrite psoriásica sob terapia anti-TNFα Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy
by: Vilma S Trindade Viana, et al.
Published: (2010-06-01)

Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy
by: Rachel Byng-Maddick, et al.
Published: (2017-08-01)

IgA deficiency evidence after anti-TNF-α treatment in a psoriatic arthritis patient: case report
by: R. Scarpa, et al.
Published: (2012-03-01)

Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
by: Alexis Ogdie, et al.
Published: (2022-11-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

Effects of TNF-α inhibition secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis
by: Ashley Elliott, et al.
Published: (2023-11-01)

Hypoglycemia: a review of definitions used in clinical trials evaluating antihyperglycemic drugs for diabetes
by: Balijepalli C, et al.
Published: (2017-05-01)

Immunohistochemical analysis of the expression of main adhesion molecules and tumor necrosis factors in the synovial membrane of psoriatic arthritis
by: V. Riccieri, et al.
Published: (2003-09-01)

Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice
by: Marta Fabbroni, et al.
Published: (2014-01-01)

Complexity of immunobiology of tumor necrosis factor and novel anti-TNF therapy
by: S. А. Nedospasov
Published: (2023-06-01)

Psoriatic arthritis
by: FitzGerald, O, et al.
Published: (2021)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
by: Nikolay N. Murashkin, et al.
Published: (2020-12-01)

TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.
by: Maini, R, et al.
Published: (1993)

<I>TNF-α</I> gene expression in immune cells of patients with psoriasis and psoriatic arthritis
by: V. V. Sobolev, et al.
Published: (2022-08-01)

ANTI TNF THERAPY IN RHEUMATOID ARTHRITIS
by: Feldmann, M, et al.
Published: (2011)

The effects of tumor necrosis factor (TNF) derivatives on TNF receptors.
by: Tchorzewski, H, et al.
Published: (1993)

Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
by: Alexis Ogdie, et al.
Published: (2023-04-01)

Retention rate of tumor necrosis factor inhibitors, anti-interleukin 17, and anti-interleukin 12/23 drugs in a single-center cohort of psoriatic arthritis patients
by: M. Ferrito, et al.
Published: (2023-07-01)

Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment
by: Farida Benhadou, et al.
Published: (2021-06-01)

First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis: a prospective observational study
by: Michael Ruberson Ribeiro da Silva, et al.
Published: (2022-08-01)

Pharmacotherapies for chronic obstructive pulmonary disease: a multiple treatment comparison meta-analysis
by: Ghement I, et al.
Published: (2011-03-01)

Gamma-glutamyl transpeptidase and indirect bilirubin may participate in systemic inflammation of patients with psoriatic arthritis
by: Xu Wang, et al.
Published: (2023-10-01)

Single nucleotide polymorphisms in the tumor necrosis factor-alpha gene promoter region alter the risk of psoriasis vulgaris and psoriatic arthritis: a meta-analysis.
by: Junqing Zhu, et al.
Published: (2013-01-01)

Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study
by: Joseph Sexton, et al.
Published: (2022-12-01)